Skip to main content

Table 2 Common medical comorbidities at baseline and selected follow-up in patients with and without BD

From: Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis

 

Baseline (6-months pre-index date)

Selected Follow-up (12 months post-index)

With BD (N = 16,440)

Without BD (N = 86,962)

P Value

With BD (N = 11,440)

Without BD (N = 54,516)

P Value

Medical Comorbidities (%)

 Hypertension

55.3%

58.0%

<  0.001

80.6%

77.7%

<  0.001

 Dyslipidemia

23.4%

26.7%

<  0.001

41.2%

42.8%

0.001

 Diabetes

24.1%

25.5%

<  0.001

30.8%

30.3%

0.332

 Cerebrovascular disease

20.2%

21.0%

0.019

39.7%

34.5%

<  0.001

 Urinary tract infection

17.8%

15.4%

<  0.001

39.6%

27.2%

<  0.001

 Chronic Pulmonary Disease

14.4%

16.3%

<  0.001

25.1%

24.1%

0.021

 Congestive Heart Failure

12.9%

13.7%

0.004

23.7%

20.9%

<  0.001

 Peripheral vascular disease

8.4%

8.9%

0.068

18.4%

15.6%

<  0.001

 Hip fracture and other fractures

10.1%

9.5%

0.024

21.1%

16.0%

<  0.001

 Malignancy

8.0%

9.8%

<  0.001

11.6%

13.3%

<  0.001

 Malnutrition

2.4%

2.0%

0.0004

6.1%

3.8%

<  0.001

 Pneumonia

6.8%

7.1%

0.231

17.4%

13.3%

<  0.001

Psychiatric Conditions (%)

 Mood disorder

16.7%

13.3%

<  0.001

41.6%

25.7%

<  0.001

 Depression

16.0%

12.4%

<  0.001

40.4%

24.4%

<  0.001

 Delirium

6.95%

4.57%

<  0.001

21.0%

9.5%

<  0.001

 Psychotic disorders

19.0%

12.0%

<  0.001

46.7%

21.4%

<  0.001

 Psychosis

16.1%

10.1%

<  0.001

39.7%

17.8%

<  0.001

 Altered Mental State

16.9%

11.4%

<  0.001

43.1%

21.6%

<  0.001

 Anxiety Disorder

9.1%

7.2%

<  0.001

26.1%

14.6%

<  0.001

  1. BD behavioral disturbance